Description

PT-141 is a laboratory-engineered peptide derived from melanocortin analog research, developed to selectively engage melanocortin receptors associated with central nervous system signaling. In experimental models, it demonstrates affinity for MC3R and MC4R, receptors involved in hypothalamic signaling networks and neuropeptide communication.

Because of its receptor profile, PT-141 is frequently used in research settings to examine GPCR activation patterns, downstream neuronal signaling pathways, and broader neuroendocrine regulatory mechanisms. Its structure and signaling behavior make it a useful tool for studying central melanocortin system dynamics under controlled laboratory conditions.

This compound is intended strictly for research use only and is not approved for human consumption, therapeutic application, or diagnostic use.

Selected research sources include:
Wessells H. et al., Journal of Urology (2003)
Shadiack A.M. et al., Journal of Sexual Medicine (2007)
Hadley M.E., Annals of the New York Academy of Sciences (2006)